Los Angeles Capital Management LLC Altimmune, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 31,197 shares of ALT stock, worth $190,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,197
Previous 66,537
53.11%
Holding current value
$190,613
Previous $408,000
45.1%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALT
# of Institutions
208Shares Held
39.5MCall Options Held
1.94MPut Options Held
1.38M-
Black Rock Inc. New York, NY5.32MShares$32.5 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$32.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$27.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$21.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$16.8 Million1.49% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $300M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...